Healthcare
OrbiMed et al. in $35m series-A for Therachon
Injection follows seed round for business in 2014
MML acquires Energy Medical Services
GP plans on following buy-and-build strategy
Wales Life Sciences Fund leads €12m series-B for Apitope
Cash will fund drug development and move to Wales
Sofinnova backs Asceneuron's CHF 30m series-A
Company is a spin-off from Merck Serono
Karolinska Development exits XSpray Microparticles
New owner will invest SEK 18m to support clinical trials
Parquest et al. buy Creadev's Homeperf
Creadev had acquired business from minority owner 3i in 2009
Hannover Finanz acquires Frey&Winkler
GP hopes for good returns from medical engineerer
Bridgepoint acquires Balt
Second French foray for GP’s €4bn fifth buyout fund
EQT eyes PLN 200m HTL-Strefa listing
GP targets late October for Warsaw listing
SHS and BWK buy minority stake in NDD Medizintechnik
Company operates in Europe, the US and Asia
Deal in Focus: Forbion to reap 50x on $1.55bn Dezima sale
Sale of Dezima could result in a staggering 50x return for Forbion
Finance Wales-backed Creo Medical raises $8.45m
Welsh medical equipment maker has raised $20.7m to date
Forbion's Dezima sold to Amgen
VC exits two years after backing the company's creation
Omnes et al. in funding round for SeniorAdom
Business eyeing international expansion in 2016
Catapult exits Lumora
Catapult first invested in the company in 2011
VC-backed Acacia to list in October
Offering size understood to lie around the ТЃ150m mark
Go Capital et al. in €2.2m seed round for Mitricares
Second round to feature a French implant designer in a week
New Science Ventures et al. in €28m series-A for Novadip
Largest Benelux early-stage round recorded by unquote” so far in 2015
Gimv et al. in €31.3m series-C for Biom'up
Round comes three years after €6.8m series-B
Cinven exits AmCo in £2.3bn trade sale
GP built group via merger of Mercury Pharma and Amdipharm
Siparex exits Tetra Medical to 3T Group
Exit is Siparex's latest after active summer on sell-side
Duke Street sells Baywater's Irish subsidiary
Duke Street acquired Baywater in December 2014
Auven's ADC Therapeutics raises $80m
Company is active in Europe and the US
Cequr raises $100m series-C
Insulin infusion device to go on sale next year